Immunocytology in the Assessment of Patients with Asymptomatic Microhaematuria

European Urology

Volumn 51, Issue 6, 2007, Pages 1582-1588

  Schmitz Dräger, Bernd J ^a   Beiche, Birgit ^a,b   Tirsar, Lenuta Ancuta ^a   Schmitz Dräger, Claudia ^a   Bismarck, Ekkehardt ^a   Ebert, Thomas ^a  

^a Urologie   (Germany)

^b KLINIKUM BAMBERG   (Germany)

Author keywords

Bladder cancer; Immunocytology; Microhaematuria

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HEMATURIA; HUMAN; IDIOPATHIC DISEASE; INTERSTITIAL CYSTITIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PATIENT ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINARY TRACT INFECTION; URINE CYTOLOGY; UROGENITAL ENDOSCOPY; UROGENITAL TRACT TUMOR; UROLITHIASIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; URINE; UROLOGIC DISEASES;

EID: 34247550681     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.10.046     Document Type: Article

References (24)

1. Lokeshwar V.B., Habuchi T., Grossman H.B., et al. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology 66 6 Suppl 1 (2005) 35-63
2. Jichlinski P. New diagnostic strategies in the detection and staging of bladder cancer. Curr Opin Urol 3 (2003) 351-355
3. Fradet Y., and Lockhart C. Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt™. Can J Urol 4 (1997) 400-405
4. Jaffe J.S., Ginsberg P.C., Gill R., and Harkaway R.C. A new diagnostic algorithm for the evaluation of microscopic hematuria. Urology 57 (2001) 889-894
5. Wiener H.G., Mian C., Haitel A., et al. Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?. J Urol 159 (1998) 1876-1880
6. Oosterlinck W., Lobel B., Jakse G., et al. Guidelines on bladder cancer. Eur Urol 41 (2002) 105-112
7. Mian C., Pycha A., Wiener H., et al. Immunocyt: a new tool for detecting transitional cell cancer of the urinary tract. J Urol 161 (1999) 1486-1489
8. Lodde M., Mian C., Negri G., et al. Role of uCyt+ in the detection and surveillance of urothelial carcinoma. Urology 61 (2003) 243-247
9. Goebell P.J., Groshen S., Schmitz-Dräger B.J., et al. The international Bladder Cancer Bank-proposal for a new study concept. Urol Oncol 22 (2004) 277-284
10. Pfister C., Chautard D., Devonec M., et al. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. J Urol 169 (2003) 921-924
11. Vriesema J.L., Atsma F., Kiemeney L.A., et al. Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence. Urology 58 (2001) 367-371
12. Sarosdy M.F., Kahn P.R., Ziffer M.D., et al. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol 176 (2006) 44-47
13. Khan M.A., Shaw G., and Paris A.M. Is microscopic haematuria a urological emergency?. BJU Int 90 (2002) 355-357
14. Fracchia J.A., Motta J., Miller L.S., et al. Evaluation of asymptomatic microhematuria. Urology 46 (1995) 484-489
15. Boman H., Hedelin H., Jacobsson S., and Holmang S. Newly diagnosed bladder cancer: the relationship of initial symptoms, degree of microhematuria and tumor marker status. J Urol 168 (2002) 1955-1959
16. van der Poel H.G., Boon M.E., van Stratum P., et al. Conventional bladder wash cytology performed by four experts versus quantitative image analysis. Mod Pathol 10 (1997) 976-982
17. Beiche B., Ebert T., and Schmitz-Dräger B.J. Immunzytologie in der Diagnostik des Urothelkarzinoms-ein reproduzierbares Testverfahren?. Urologe A 41 suppl 1 (2002) 45
18. Paez A., Coba J.M., Murillo N., et al. Reliability of the routine cytological diagnosis in bladder cancer. Eur Urol 35 (1999) 228-232
19. Schmitz-Dräger B.J., Strich W.E., Gerke R., et al. Filter immunocytology (FLIC)-methodological evaluation of a new assay for diagnosis of urothelial cancer. Acta Cytol 40 (1996) 269-276
20. Olsson H., and Zackrisson B. ImmunoCyt a useful method in the follow-up protocol for patients with urinary bladder carcinoma. Scand J Urol Nephrol 35 (2001) 280-282
21. Feil G., Zumbragel A., Paulgen-Nelde H.J., et al. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder. Anticancer Res 23 2A (2003) 963-967
22. Fradet Y. Recent advances in the management of superficial bladder tumors. Can J Urol 9 (2002) 1544-1550
23. Messing E.M., Teot L., Korman H., et al. Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States. J Urol 174 (2005) 1238-1241
24. Toma M.I., Friedrich M.G., Hautmann S.H., et al. Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer. World J Urol 22 (2004) 145-149